Amyloid β Protein: Aβ40 Inhibits Aβ42 Oligomerization-Reference-Cited by-同舟云学术

Amyloid β Protein: Aβ40 Inhibits Aβ42 Oligomerization

Published:2009-04-22 Issue:18 Volume:131 Page:6316-6317
ISSN:0002-7863
Container-title:Journal of the American Chemical Society
language:en
Short-container-title:J. Am. Chem. Soc.

Author:

Murray Megan M.¹,Bernstein Summer L.¹,Nyugen Vy¹,Condron Margaret M.¹,Teplow David B.¹,Bowers Michael T.¹

Affiliation:

1. Department of Chemistry and Biochemistry, University of California, Santa Barbara, California 93106-950, and Department of Neurology, David Geffen School of Medicine, and Molecular Biology Institute and Brain Research Institute, University of California, Los Angeles, California 90095

Publisher

American Chemical Society (ACS)

Subject

Colloid and Surface Chemistry,Biochemistry,General Chemistry,Catalysis

Link

https://pubs.acs.org/doi/pdf/10.1021/ja8092604

Reference20 articles.

1. Amyloid β-Protein Assembly and Alzheimer Disease

2. Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability

3. Amyloid -protein (A ) assembly: A 40 and A 42 oligomerize through distinct pathways

4. A specific amyloid-β protein assembly in the brain impairs memory

5. Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer’s disease

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-Molecule Characterization of Heterogeneous Oligomer Formation during Co-Aggregation of 40- and 42-Residue Amyloid-β;Journal of the American Chemical Society;2024-08-23

2. Comparison between sub-chronic and chronic sleep deprivation-induced behavioral and neuroimmunological abnormalities in mice: Focusing on glial cell phenotype polarization;Behavioural Brain Research;2024-07

3. Insulin Signaling Differentially Regulates the Trafficking of Insulin and Amyloid Beta Peptides at the Blood–Brain Barrier;Molecular Pharmaceutics;2024-04-16

4. Decoding the role of gut microbiota in Alzheimer’s pathogenesis and envisioning future therapeutic avenues;Frontiers in Neuroscience;2023-09-18

5. Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study;Alzheimer's Research & Therapy;2023-08-30